Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott M Dehm

Showing results (101-110 of 130) with videos related to

Pageof 13
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2025
Structurally Oriented Classification of FOXA1 Alterations Identifies Prostate Cancers with Opposing Clinical Outcomes and Distinct Molecular and Immunologic SubtypesJustin Hwang, Pornlada Likasitwatanakul, Sachin Kumar Deshmukh, et al.
Cancer Research Communications|May 6, 2024
Pan-Cancer Interrogation of B7-H3 (CD276) as an Actionable Therapeutic Target Across Human MalignanciesCarly D Miller, John R Lozada, Nicholas A Zorko, et al.
Genome Biology|April 16, 2026
Convergent evolution of complex structural variants drives therapy resistance in metastatic prostate cancerThaidy Moreno-Rodriguez, Meng Zhang, Arian Lundberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2023
Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate CancerJamie M Sperger, Kyle T Helzer, Charlotte N Stahlfeld, et al.
Cancer Immunology Research|November 15, 2024
A PSMA-Targeted Tri-Specific Killer Engager Enhances NK Cell Cytotoxicity against Prostate CancerShee Kwan Phung, Nicholas A Zorko, Yvette Soignier, et al.
European Urology Focus|April 12, 2025
Reprogramming of Androgen Receptor Activity in Castration-resistant Prostate Cancer is Shaped by Truncated VariantsMitchell G Lawrence, Shivakumar Keerthikumar, Scott L Townley, et al.
Nature Communications|March 20, 2026
Tumor-specific lncRNA IGF1R-AS1 trans-regulates chromatin interactions associated with oncogenic MYC signalingYongyong Yang, Ting-You Wang, Joshua Fry, et al.
Cancer Research|July 30, 2017
Androgen Receptor Variants Mediate DNA Repair after Prostate Cancer IrradiationYi Yin, Rui Li, Kangling Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2025
Germline-Somatic Interactions in BRCA-Associated Cancers: Unique Molecular Profiles and Clinical Outcomes Linking ATM to TP53 Synthetic EssentialityAli T Arafa, Siddhartha Yadav, Catherine H Marshall, et al.
European Urology|December 21, 2017
Role of Androgen Receptor Variants in Prostate Cancer: Report from the 2017 Mission Androgen Receptor Variants MeetingJun Luo, Gerhardt Attard, Steven P Balk, et al.
Pageof 13

Showing results (101-110 of 130) with videos related to

Sort By:
Pageof 13
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2025
Structurally Oriented Classification of FOXA1 Alterations Identifies Prostate Cancers with Opposing Clinical Outcomes and Distinct Molecular and Immunologic SubtypesJustin Hwang, Pornlada Likasitwatanakul, Sachin Kumar Deshmukh, et al.
Cancer Research Communications|May 6, 2024
Pan-Cancer Interrogation of B7-H3 (CD276) as an Actionable Therapeutic Target Across Human MalignanciesCarly D Miller, John R Lozada, Nicholas A Zorko, et al.
Genome Biology|April 16, 2026
Convergent evolution of complex structural variants drives therapy resistance in metastatic prostate cancerThaidy Moreno-Rodriguez, Meng Zhang, Arian Lundberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2023
Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate CancerJamie M Sperger, Kyle T Helzer, Charlotte N Stahlfeld, et al.
Cancer Immunology Research|November 15, 2024
A PSMA-Targeted Tri-Specific Killer Engager Enhances NK Cell Cytotoxicity against Prostate CancerShee Kwan Phung, Nicholas A Zorko, Yvette Soignier, et al.
European Urology Focus|April 12, 2025
Reprogramming of Androgen Receptor Activity in Castration-resistant Prostate Cancer is Shaped by Truncated VariantsMitchell G Lawrence, Shivakumar Keerthikumar, Scott L Townley, et al.
Nature Communications|March 20, 2026
Tumor-specific lncRNA IGF1R-AS1 trans-regulates chromatin interactions associated with oncogenic MYC signalingYongyong Yang, Ting-You Wang, Joshua Fry, et al.
Cancer Research|July 30, 2017
Androgen Receptor Variants Mediate DNA Repair after Prostate Cancer IrradiationYi Yin, Rui Li, Kangling Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2025
Germline-Somatic Interactions in BRCA-Associated Cancers: Unique Molecular Profiles and Clinical Outcomes Linking ATM to TP53 Synthetic EssentialityAli T Arafa, Siddhartha Yadav, Catherine H Marshall, et al.
European Urology|December 21, 2017
Role of Androgen Receptor Variants in Prostate Cancer: Report from the 2017 Mission Androgen Receptor Variants MeetingJun Luo, Gerhardt Attard, Steven P Balk, et al.
Pageof 13